We are live on ! Find out more
NRD

Nebula Research & Development Portfolio holdings

AUM $1.17B
1-Year Est. Return 15.19%
This Fund
S&P 500
This Quarter Est. Return
+7.19%
1 Year Est. Return
+15.19%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$836M
AUM Growth
+$219M
Cap. Flow
+$188M
Cap. Flow %
22.5%
Top 10 Hldgs %
4.49%
Holding
1,220
New
441
Increased
247
Reduced
213
Closed
319

Top Buys

Rank Stock Value
1
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$4.41M
2
AAP icon
Advance Auto Parts
AAP
+$4.15M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$3.96M
4
DLTR icon
Dollar Tree
DLTR
+$3.82M
5
MSFT icon
Microsoft
MSFT
+$3.74M

Top Sells

Rank Stock Value
1
BAC icon
Bank of America
BAC
+$2.82M
2
KO icon
Coca-Cola
KO
+$2.82M
3
GD icon
General Dynamics
GD
+$2.82M
4
ORCL icon
Oracle
ORCL
+$2.81M
5
HLNE icon
Hamilton Lane
HLNE
+$2.8M

Sector Composition

Rank Sector Weight
1 Technology 16.51%
2 Industrials 15.72%
3 Consumer Discretionary 15.68%
4 Healthcare 13.43%
5 Financials 10.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
A icon
501
Agilent Technologies
A
$39.7B
$570K 0.07%
+3,842
New +$526K
XPRO icon
502
Expro Ltd
XPRO
$1.75B
$569K 0.07%
+33,166
New +$674K
BRSL
503
Brightstar Lottery PLC
BRSL
$1.92B
$569K 0.07%
26,692
-72,363
-73% -$1.55M
CTSH icon
504
Cognizant
CTSH
$23.8B
$568K 0.07%
+7,363
New +$549K
OMF icon
505
OneMain Financial
OMF
$7.19B
$568K 0.07%
+12,058
New +$580K
OLO
506
DELISTED
Olo Inc
OLO
$567K 0.07%
+114,278
New +$565K
SPSC icon
507
SPS Commerce
SPSC
$2.51B
$563K 0.07%
2,897
-5,781
-67% -$1.13M
TPG icon
508
TPG
TPG
$7.02B
$561K 0.07%
9,744
-18,195
-65% -$896K
CVCO icon
509
Cavco Industries
CVCO
$4.54B
$560K 0.07%
1,308
+172
+15% +$67.9K
LUMN icon
510
Lumen
LUMN
$6.38B
$559K 0.07%
+78,765
New +$336K
BCO icon
511
Brink's
BCO
$4.87B
$557K 0.07%
4,815
-5,878
-55% -$622K
ACAD icon
512
Acadia Pharmaceuticals
ACAD
$4.45B
$557K 0.07%
36,196
-64,082
-64% -$1.07M
CRS icon
513
Carpenter Technology
CRS
$27.8B
$556K 0.07%
3,487
-9,941
-74% -$1.35M
CWK icon
514
Cushman & Wakefield Ltd
CWK
$3.2B
$551K 0.07%
+40,443
New +$510K
WOLF icon
515
Wolfspeed
WOLF
$1.14B
$551K 0.07%
+56,805
New +$836K
DV icon
516
DoubleVerify
DV
$1.73B
$549K 0.07%
+32,625
New +$622K
ECHO
517
EchoStar
ECHO
$24.9B
$548K 0.07%
22,083
+2,306
+12% +$47.1K
ABNB icon
518
Airbnb
ABNB
$90.9B
$547K 0.07%
+4,317
New +$560K
AGO icon
519
Assured Guaranty
AGO
$3.79B
$546K 0.07%
6,871
+3,260
+90% +$257K
HOLX
520
DELISTED
Hologic
HOLX
$545K 0.07%
+6,695
New +$536K
BE icon
521
Bloom Energy
BE
$47.5B
$544K 0.07%
51,521
+15,196
+42% +$180K
AYI icon
522
Acuity Brands
AYI
$10.3B
$542K 0.06%
1,967
+456
+30% +$113K
CPNG icon
523
Coupang
CPNG
$27.7B
$542K 0.06%
22,059
-19,878
-47% -$442K
FORM icon
524
FormFactor
FORM
$6.88B
$541K 0.06%
11,758
-7,274
-38% -$363K
VIK icon
525
Viking Holdings
VIK
$46.6B
$539K 0.06%
+15,462
New +$529K
19 20
21
22 23

Similar funds

SAF
Smith Anglin Financial Dallas, Texas $1.1B AUM 14.08% 1-Year Est. Return
GIM
Grassi Investment Management Santa Clara, California $1.26B AUM 23.4% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
PP
PrairieView Partners St. Paul, Minnesota $1.03B AUM 11.4% 1-Year Est. Return
FC
Forte Capital Rochester, New York $930M AUM 24.11% 1-Year Est. Return
HIP
HPS Investment Partners New York $1.52B AUM 19.81% 1-Year Est. Return
SC
Savoie Capital Chicago, Illinois $805M AUM 19.48% 1-Year Est. Return
BWA
Bordeaux Wealth Advisors Menlo Park, California $781M AUM 26.55% 1-Year Est. Return

Nebula Research & Development's Q3 2024 Portfolio in Review

As of Q3 2024, Nebula Research & Development held 1,220 positions worth $836M, up 35% from $618M the previous quarter. Its ten largest holdings account for 4.5% of the portfolio.

Nebula Research & Development deployed $188M of net new capital in Q3 2024, opening 441 new positions and adding to 247 existing holdings. Its largest new stake was BioMarin Pharmaceuticals: 52,699 shares worth $3.7M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Travelers Companies, an estimated $2.39M trimmed.

  • Nebula Research & Development's largest Q3 2024 buy was BioMarin Pharmaceuticals: 52,699 shares worth $3.7M.
  • Nebula Research & Development added most to Dollar Tree in Q3 2024, an estimated $3.82M increase.
  • Nebula Research & Development's biggest Q3 2024 reduction was Travelers Companies, cutting an estimated $2.39M.
  • Nebula Research & Development fully exited Bank of America in Q3 2024, selling an estimated $2.82M.
  • Nebula Research & Development's ten largest holdings make up 4.5% of its $836M portfolio in Q3 2024.
  • Nebula Research & Development opened 441 new positions and closed 319 in Q3 2024.
  • Nebula Research & Development's portfolio value rose 35% quarter-over-quarter to $836M.

Based on Nebula Research & Development's 13F filing for Q3 2024, filed 14 Nov 2024.